Intracellular distribution of functional M1-muscarinic acetylcholine receptors in N1E-115 neuroblastoma cells

Journal of Neurochemistry

Volumn 118, Issue 6, 2011, Pages 958-967

  Uwada, Junsuke ^a   Anisuzzaman, Abu Syed Md ^a   Nishimune, Atsushi ^a   Yoshiki, Hatsumi ^a   Muramatsu, Ikunobu ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

ERK1 2; intracellular GPCR; MAP kinase; muscarinic receptor; N1E 115; neuroblastoma

Indexed keywords

CALCIUM ION; CARBACHOL; METHYLSCOPOLAMINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MUSCARINIC M1 RECEPTOR; MUSCARINIC M1 RECEPTOR ANTAGONIST; MUSCARINIC TOXIN 7; PHOSPHATIDYLINOSITOL; PIRENZEPINE; PROTEIN KINASE C; QUINUCLIDINYL BENZILATE; UNCLASSIFIED DRUG; YM 254890;

ARTICLE; CALCIUM MOBILIZATION; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CELL SURFACE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; IMMUNOHISTOCHEMISTRY; INTRACELLULAR MEMBRANE; NEUROBLASTOMA CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ATROPINE; BLOTTING, WESTERN; CALCIUM; CARBACHOL; CELL LINE, TUMOR; ELAPID VENOMS; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; IMMUNOHISTOCHEMISTRY; INOSITOL PHOSPHATES; KINETICS; MICE; MUSCARINIC AGONISTS; MUSCARINIC ANTAGONISTS; N-METHYLSCOPOLAMINE; NEUROBLASTOMA; PEPTIDES, CYCLIC; PIRENZEPINE; PROTEIN KINASE INHIBITORS; QUINUCLIDINYL BENZILATE; RECEPTOR, MUSCARINIC M1; RECEPTORS, CELL SURFACE;

EID: 80052348922     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2011.07378.x     Document Type: Article

References (44)

1. Ahn S., Shenoy S. K., Wei H., and, Lefkowitz R. J., (2004) Differential kinetic and spatial patterns of beta-arrestin and G protein-mediated ERK activation by the angiotensin II receptor. J. Biol. Chem., 279, 35518-35525. (Pubitemid 39100552)
2. Berkeley J. L., and, Levey A. I., (2000) Muscarinic activation of mitogen-activated protein kinase in PC12 cells. J. Neurochem., 75, 487-493. (Pubitemid 30485429)
3. Blokland A., (1995) Acetylcholine: a neurotransmitter for learning and memory? Brain Res. Brain Res. Rev., 21, 285-300. (Pubitemid 26188014)
4. Boivin B., Lavoie C., Vaniotis G., Baragli A., Villeneuve L. R., Ethier N., Trieu P., Allen B. G., and, Hebert T. E., (2006) Functional beta-adrenergic receptor signalling on nuclear membranes in adult rat and mouse ventricular cardiomyocytes. Cardiovasc. Res., 71, 69-78. (Pubitemid 43849672)
5. Brown D. A., (2010) Muscarinic acetylcholine receptors (mAChRs) in the nervous system: some functions and mechanisms. J. Mol. Neurosci., 41, 340-346.
6. Caccamo A., Oddo S., Billings L. M., Green K. N., Martinez-Coria H., Fisher A., and, LaFerla F. M., (2006) M1 receptors play a central role in modulating AD-like pathology in transgenic mice. Neuron, 49, 671-682. (Pubitemid 43290127)
7. Caulfield M. P., and, Birdsall N. J., (1998) International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol. Rev., 50, 279-290. (Pubitemid 28304029)
8. Conn P. J., Jones C. K., and, Lindsley C. W., (2009) Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders. Trends Pharmacol. Sci., 30, 148-155.
9. Defea K., (2008) Beta-arrestins and heterotrimeric G-proteins: collaborators and competitors in signal transduction. Br. J. Pharmacol., 153 (Suppl. 1), S298-S309.
10. Eglen R. M., Choppin A., and, Watson N., (2001) Therapeutic opportunities from muscarinic receptor research. Trends Pharmacol. Sci., 22, 409-414. (Pubitemid 32718632)
11. Felder C. C., (1995) Muscarinic acetylcholine receptors: signal transduction through multiple effectors. FASEB J., 9, 619-625.
12. Flynn D. D., Ferrari-DiLeo G., Levey A. I., and, Mash D. C., (1995) Differential alterations in muscarinic receptor subtypes in Alzheimer's disease: implications for cholinergic-based therapies. Life Sci., 56, 869-876.
13. Fraeyman N. H., Buyse M. A., and, Lefebvre R. A., (1991) Study of the muscarinic receptor subtypes in N1E 115 mouse neuroblastoma cells. Pharmacol. Res., 23, 33-40.
14. Gobeil F., Jr, Vazquez-Tello A., Marrache A. M., Bhattacharya M., Checchin D., Bkaily G., Lachapelle P., Ribeiro-Da-Silva A., and, Chemtob S., (2003) Nuclear prostaglandin signaling system: biogenesis and actions via heptahelical receptors. Can. J. Physiol. Pharmacol., 81, 196-204. (Pubitemid 36398894)
15. Guo F. F., Kumahara E., and, Saffen D., (2001) A CalDAG-GEFI/Rap1/B-Raf cassette couples M(1) muscarinic acetylcholine receptors to the activation of ERK1/2. J. Biol. Chem., 276, 25568-25581.
16. Hamilton S. E., and, Nathanson N. M., (2001) The M1 receptor is required for muscarinic activation of mitogen-activated protein (MAP) kinase in murine cerebral cortical neurons. J. Biol. Chem., 276, 15850-15853.
17. Haring R., Fisher A., Marciano D., Pittel Z., Kloog Y., Zuckerman A., Eshhar N., and, Heldman E., (1998) Mitogen-activated protein kinase-dependent and protein kinase C-dependent pathways link the m1 muscarinic receptor to beta-amyloid precursor protein secretion. J. Neurochem., 71, 2094-2103. (Pubitemid 28491566)
18. Iredale P. A., Martin K. F., Hill S. J., and, Kendall D. A., (1992) Agonist-induced changes in [Ca2+]i in N1E-115 cells: differential effects of bradykinin and carbachol. Eur. J. Pharmacol., 226, 163-168.
19. Israilova M., Tanaka T., Suzuki F., Morishima S., and, Muramatsu I., (2004) Pharmacological characterization and cross talk of alpha1a- and alpha1b-adrenoceptors coexpressed in human embryonic kidney 293 cells. J. Pharmacol. Exp. Ther., 309, 259-266. (Pubitemid 38393138)
20. Jiang X., Sinnett-Smith J., and, Rozengurt E., (2009) Carbachol induces p70S6K1 activation through an ERK-dependent but Akt-independent pathway in human colonic epithelial cells. Biochem. Biophys. Res. Commun., 387, 521-524.
21. Jong Y. J., Kumar V., and, O'Malley K. L., (2009) Intracellular metabotropic glutamate receptor 5 (mGluR5) activates signaling cascades distinct from cell surface counterparts. J. Biol. Chem., 284, 35827-35838.
22. Langmead C. J., Watson J., and, Reavill C., (2008) Muscarinic acetylcholine receptors as CNS drug targets. Pharmacol. Ther., 117, 232-243.
23. Lee D. K., Lanca A. J., Cheng R., Nguyen T., Ji X. D., Gobeil F., Jr, Chemtob S., George S. R., and, O'Dowd B. F., (2004) Agonist-independent nuclear localization of the Apelin, angiotensin AT1, and bradykinin B2 receptors. J. Biol. Chem., 279, 7901-7908. (Pubitemid 38294677)
24. Lee K. S., Nishimune A., Yoshiki H., Anisuzzaman A. S., Suzuki F., Wang M. H., Cheng J. T., and, Muramatsu I., (2010) Assessment of novel muscarinic acetylcholine receptors in rat cerebral cortex by a tissue segment binding method. J. Pharmacol. Sci., 112, 444-451.
25. Lind G. J., and, Cavanagh H. D., (1993) Nuclear muscarinic acetylcholine receptors in corneal cells from rabbit. Invest. Ophthalmol. Vis. Sci., 34, 2943-2952. (Pubitemid 23269149)
26. Mufson E. J., Counts S. E., Perez S. E., and, Ginsberg S. D., (2008) Cholinergic system during the progression of Alzheimer's disease: therapeutic implications. Expert Rev. Neurother., 8, 1703-1718.
27. Narushima M., Uchigashima M., Fukaya M., Matsui M., Manabe T., Hashimoto K., Watanabe M., and, Kano M., (2007) Tonic enhancement of endocannabinoid- mediated retrograde suppression of inhibition by cholinergic interneuron activity in the striatum. J. Neurosci., 27, 496-506. (Pubitemid 46143754)
28. Olianas M. C., Ingianni A., Maullu C., Adem A., Karlsson E., and, Onali P., (1999) Selectivity profile of muscarinic toxin 3 in functional assays of cloned and native receptors. J. Pharmacol. Exp. Ther., 288, 164-170. (Pubitemid 29113487)
29. Olianas M. C., Maullu C., Adem A., Mulugeta E., Karlsson E., and, Onali P., (2000) Inhibition of acetylcholine muscarinic M(1) receptor function by the M(1)-selective ligand muscarinic toxin 7 (MT-7). Br. J. Pharmacol., 131, 447-452.
30. O'Malley K. L., Jong Y. J., Gonchar Y., Burkhalter A., and, Romano C., (2003) Activation of metabotropic glutamate receptor mGlu5 on nuclear membranes mediates intranuclear Ca2+ changes in heterologous cell types and neurons. J. Biol. Chem., 278, 28210-28219. (Pubitemid 36900021)
31. Pepeu G., and, Giovannini M. G., (2010) Cholinesterase inhibitors and memory. Chem. Biol. Interact., 187, 403-408.
32. Pierce K. L., Luttrell L. M., and, Lefkowitz R. J., (2001) New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades. Oncogene, 20, 1532-1539. (Pubitemid 32336840)
33. Resende R. R., and, Adhikari A., (2009) Cholinergic receptor pathways involved in apoptosis, cell proliferation and neuronal differentiation. Cell Commun. Signal., 7, 20.
34. Robben J. H., Kortenoeven M. L., Sze M., Yae C., Milligan G., Oorschot V. M., Klumperman J., Knoers N. V., and, Deen P. M., (2009) Intracellular activation of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus by nonpeptide agonists. Proc. Natl. Acad. Sci. U S A, 106, 12195-12200.
35. Rozengurt E., (2007) Mitogenic signaling pathways induced by G protein-coupled receptors. J. Cell. Physiol., 213, 589-602. (Pubitemid 350058250)
36. Sathi Z. S., Anisuzzaman A. S., Morishima S., Suzuki F., Tanaka T., Yoshiki H., and, Muramatsu I., (2008) Different affinities of native alpha1B-adrenoceptors for ketanserin between intact tissue segments and membrane preparations. Eur. J. Pharmacol., 584, 222-228.
37. Shenoy S. K., Drake M. T., Nelson C. D., et al. (2006) Beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor. J. Biol. Chem., 281, 1261-1273.
38. Sun Y., Huang J., Xiang Y., Bastepe M., Juppner H., Kobilka B. K., Zhang J. J., and, Huang X. Y., (2007) Dosage-dependent switch from G protein-coupled to G protein-independent signaling by a GPCR. EMBO J., 26, 53-64. (Pubitemid 46094699)
39. Thomas G. M., and, Huganir R. L., (2004) MAPK cascade signalling and synaptic plasticity. Nat. Rev. Neurosci., 5, 173-183. (Pubitemid 38252474)
40. Tsang S. W., Lai M. K., Kirvell S., Francis P. T., Esiri M. M., Hope T., Chen C. P., and, Wong P. T., (2006) Impaired coupling of muscarinic M1 receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer's disease. Neurobiol. Aging, 27, 1216-1223. (Pubitemid 44088578)
41. Volpicelli L. A., and, Levey A. I., (2004) Muscarinic acetylcholine receptor subtypes in cerebral cortex and hippocampus. Prog. Brain Res., 145, 59-66. (Pubitemid 37442934)
42. Wess J., Eglen R. M., and, Gautam D., (2007) Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development. Nat. Rev. Drug Discov., 6, 721-733. (Pubitemid 47342315)
43. Wright C. D., Chen Q., Baye N. L., Huang Y., Healy C. L., Kasinathan S., and, O'Connell T. D., (2008) Nuclear alpha1-adrenergic receptors signal activated ERK localization to caveolae in adult cardiac myocytes. Circ. Res., 103, 992-1000.
44. Yamasaki M., Matsui M., and, Watanabe M., (2010) Preferential localization of muscarinic M1 receptor on dendritic shaft and spine of cortical pyramidal cells and its anatomical evidence for volume transmission. J. Neurosci., 30, 4408-4418.